As the published studies showed that LBX2-AS1 was associated with poor prognosis of patients with hepatocellular carcinoma and non-small cell lung cancer [13, 14], the findings suggested that LBX2-AS1 might be a predictive biomark for a variety of cancer types. Here, LBX2 is linked to hepatocellular carcinoma.